223 related articles for article (PubMed ID: 31155228)
1. A review of published anticholinergic scales and measures and their applicability in database analyses.
Lozano-Ortega G; Johnston KM; Cheung A; Wagg A; Campbell NL; Dmochowski RR; Ng DB
Arch Gerontol Geriatr; 2020; 87():103885. PubMed ID: 31155228
[TBL] [Abstract][Full Text] [Related]
2. An Evaluation of Longitudinal Measures of Anticholinergic Exposure for Application in Retrospective Administrative Data Analyses.
Lozano-Ortega G; Szabo SM; Cheung A; Suehs B; Caplan EO; Wagg A; Campbell N; Dmochowski R; Rogula B; Ng DB
Adv Ther; 2019 Sep; 36(9):2247-2259. PubMed ID: 31385284
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review.
Salahudeen MS; Duffull SB; Nishtala PS
BMC Geriatr; 2015 Mar; 15():31. PubMed ID: 25879993
[TBL] [Abstract][Full Text] [Related]
4. Systematic review on the use of anticholinergic scales in poly pathological patients.
Villalba-Moreno AM; Alfaro-Lara ER; Pérez-Guerrero MC; Nieto-Martín MD; Santos-Ramos B
Arch Gerontol Geriatr; 2016; 62():1-8. PubMed ID: 26518612
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews.
Welsh TJ; van der Wardt V; Ojo G; Gordon AL; Gladman JRF
Drugs Aging; 2018 Jun; 35(6):523-538. PubMed ID: 29736815
[TBL] [Abstract][Full Text] [Related]
6. [Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].
Javelot H; Meyer G; Becker G; Post G; Runge V; Pospieszynski P; Schneiderlin T; Armand-Branger S; Michel B; Weiner L; Faria CGF; Drapier D; Fakra E; Fossati P; Haffen E; Yrondi A; Hingray C
Encephale; 2022 Jun; 48(3):313-324. PubMed ID: 34876278
[TBL] [Abstract][Full Text] [Related]
7. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.
Lisibach A; Benelli V; Ceppi MG; Waldner-Knogler K; Csajka C; Lutters M
Eur J Clin Pharmacol; 2021 Feb; 77(2):147-162. PubMed ID: 33011824
[TBL] [Abstract][Full Text] [Related]
8. Cognitive burden of anticholinergic medications in psychotic disorders.
Eum S; Hill SK; Rubin LH; Carnahan RM; Reilly JL; Ivleva EI; Keedy SK; Tamminga CA; Pearlson GD; Clementz BA; Gershon ES; Keshavan MS; Keefe RSE; Sweeney JA; Bishop JR
Schizophr Res; 2017 Dec; 190():129-135. PubMed ID: 28390849
[TBL] [Abstract][Full Text] [Related]
9. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
[TBL] [Abstract][Full Text] [Related]
10. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
[TBL] [Abstract][Full Text] [Related]
11. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
[TBL] [Abstract][Full Text] [Related]
12. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
Hsu WH; Wen YW; Chen LK; Hsiao FY
Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the 'Oldest Old': A Systematic Review of the Literature.
Cardwell K; Hughes CM; Ryan C
Drugs Aging; 2015 Oct; 32(10):835-48. PubMed ID: 26442862
[TBL] [Abstract][Full Text] [Related]
14. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
[TBL] [Abstract][Full Text] [Related]
15. Expert-based drug lists to measure anticholinergic burden: similar names, different results.
Lertxundi U; Domingo-Echaburu S; Hernandez R; Peral J; Medrano J
Psychogeriatrics; 2013 Mar; 13(1):17-24. PubMed ID: 23551407
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of anticholinergic burden of medications in older adults.
West T; Pruchnicki MC; Porter K; Emptage R
J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
[TBL] [Abstract][Full Text] [Related]
17. Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.
Crispo JA; Willis AW; Thibault DP; Fortin Y; Hays HD; McNair DS; Bjerre LM; Kohen DE; Perez-Lloret S; Mattison DR; Krewski D
PLoS One; 2016; 11(3):e0150621. PubMed ID: 26939130
[TBL] [Abstract][Full Text] [Related]
18. Use of medications with anticholinergic properties and cognitive function in a young-old community sample.
Low LF; Anstey KJ; Sachdev P
Int J Geriatr Psychiatry; 2009 Jun; 24(6):578-84. PubMed ID: 19021151
[TBL] [Abstract][Full Text] [Related]
19. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS
Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of anticholinergic risk scales in older adults.
Durán CE; Azermai M; Vander Stichele RH
Eur J Clin Pharmacol; 2013 Jul; 69(7):1485-96. PubMed ID: 23529548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]